BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - Submission Of Un-Audited Financial Result And Limited Review Report Thereon For The Quarter Ended On 30Th June, 2022.

Download	< Back
09 Aug 2022
This is in continuation of our letter dated 2nd August, 2022 regarding information of Board Meeting for consideration and approval of un-audited Financial Results for the quarter ended on 30th June, 2022. Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are pleased to submit the Un-audited Financial Results together with Limited Review Report thereon for the quarter ended 30th June 2022 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Tuesday, 9th August, 2022 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode). Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.
View all announcements for BIOFIL CHEMICALS & PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us